APA (7th ed.) Citation

Y, H., R, S., T, U., H, K., & T, I. (2026). Limits of substitution and context-dependent selective omission of Oncotype DX recurrence score testing. Breast cancer (Tokyo, Japan), 33(4), 820. https://doi.org/10.1007/s12282-026-01868-x

Chicago Style (17th ed.) Citation

Y, Horimoto, Semba R, Ushigusa T, Kusama H, and Ishikawa T. "Limits of Substitution and Context-dependent Selective Omission of Oncotype DX Recurrence Score Testing." Breast Cancer (Tokyo, Japan) 33, no. 4 (2026): 820. https://doi.org/10.1007/s12282-026-01868-x.

MLA (9th ed.) Citation

Y, Horimoto, et al. "Limits of Substitution and Context-dependent Selective Omission of Oncotype DX Recurrence Score Testing." Breast Cancer (Tokyo, Japan), vol. 33, no. 4, 2026, p. 820, https://doi.org/10.1007/s12282-026-01868-x.